Etoposide Accord Healthcare 20 mg/ml inf. sol. (conc.) i.v. vial बेल्जियम - अंग्रेज़ी - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

etoposide accord healthcare 20 mg/ml inf. sol. (conc.) i.v. vial

accord healthcare b.v. - etoposide 20 mg/ml - concentrate for solution for infusion - 20 mg/ml - etoposide 20 mg/ml - etoposide

Etoposide Accord Healthcare 20 mg/ml inf. sol. (conc.) i.v. vial बेल्जियम - अंग्रेज़ी - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

etoposide accord healthcare 20 mg/ml inf. sol. (conc.) i.v. vial

accord healthcare b.v. - etoposide 20 mg/ml - concentrate for solution for infusion - 20 mg/ml - etoposide 20 mg/ml - etoposide

Etoposide Accord Healthcare 20 mg/ml inf. sol. (conc.) i.v. vial बेल्जियम - अंग्रेज़ी - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

etoposide accord healthcare 20 mg/ml inf. sol. (conc.) i.v. vial

accord healthcare b.v. - etoposide 20 mg/ml - concentrate for solution for infusion - 20 mg/ml - etoposide 20 mg/ml - etoposide

Etoposide Accord Healthcare 20 mg/ml inf. sol. (conc.) i.v. vial बेल्जियम - अंग्रेज़ी - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

etoposide accord healthcare 20 mg/ml inf. sol. (conc.) i.v. vial

accord healthcare b.v. - etoposide 20 mg/ml - concentrate for solution for infusion - 20 mg/ml - etoposide 20 mg/ml - etoposide

ETOPOSIDE INJECTION LIQUID कनाडा - अंग्रेज़ी - Health Canada

etoposide injection liquid

teva canada limited - etoposide - liquid - 20mg - etoposide 20mg - antineoplastic agents

ETOPOSIDE INJECTION, USP SOLUTION कनाडा - अंग्रेज़ी - Health Canada

etoposide injection, usp solution

strides pharma canada inc - etoposide - solution - 20mg - etoposide 20mg - antineoplastic agents

ETOPOSIDE 20 Mg/Ml Concentrate for Soln for Inf आयरलैंड - अंग्रेज़ी - HPRA (Health Products Regulatory Authority)

etoposide 20 mg/ml concentrate for soln for inf

cipla (eu) limited - etoposide - concentrate for soln for inf - 20 mg/ml - podophyllotoxin derivatives - it is indicated in adults for the management of: resistant non-seminomatous testicular tumours in combination with other chemotherapeutic agents; small cell lung cancer, in combination with other chemotherapeutic agents; acute monoblastic leukaemia (aml m5) and acute myelomonoblastic leukaemia (aml m4) when standard induction therapy has failed (in combination with other chemotherapeutic agents).

Etoposide 100mg/5ml concentrate for solution for infusion vials यूनाइटेड किंगडम - अंग्रेज़ी - MHRA (Medicines & Healthcare Products Regulatory Agency)

etoposide 100mg/5ml concentrate for solution for infusion vials

actavis uk ltd - etoposide - solution for infusion - 20mg/1ml

Etoposide 20mg/ml concentrate for solution for infusion concentrate for solution for infusion आर्मेनिया - अंग्रेज़ी - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

etoposide 20mg/ml concentrate for solution for infusion concentrate for solution for infusion

accord healthcare limited - etoposide - concentrate for solution for infusion - 20mg/ml

TOPOSAR- etoposide injection, solution, concentrate संयुक्त राज्य - अंग्रेज़ी - NLM (National Library of Medicine)

toposar- etoposide injection, solution, concentrate

teva parenteral medicines, inc. - etoposide (unii: 6plq3cp4p3) (etoposide - unii:6plq3cp4p3) - etoposide 20 mg in 1 ml - toposar (etoposide injection) is indicated in the management of the following neoplasms: toposar (etoposide injection) in combination therapy with other approved chemotherapeutic agents in patients with refractory testicular tumors who have already received appropriate surgical, chemotherapeutic, and radiotherapeutic therapy. etoposide injection and/or capsules in combination with other approved chemotherapeutic agents as first line treatment in patients with small cell lung cancer. toposar is contraindicated in patients who have demonstrated a previous hypersensitivity to etoposide or any component of the formulation.